Stefanie Kniep PhD, PMP is an accomplished strategic program manager at Sandoz, overseeing an $800 million portfolio for the Anti-Infectives Platform since January 2020. Prior to this role, Stefanie served as Head of Operations and PMO for Drug Substance at the Schaftenau facility, leading the start-up of the BioFuture facility. With a strong background in program management within global manufacturing functions at Novartis and Sandoz, Stefanie has developed and implemented systems across multiple continents, focusing on areas such as risk management and digital transformation. Earlier career experiences include leading global quality systems at Novartis Animal Health and engaging in business process reengineering at PricewaterhouseCoopers. Stefanie holds a PhD in Pharmaceutical Technology, an MSc in Pharmacy, and has completed various relevant certifications, including a Lean Six Sigma Green Belt.